Wound Care – Part II: Tissue-engineered skin substitutes & other advanced wound therapies

Fiona Haxho(University of Calgary), Afsáneh Alavi(Mayo Clinic in Arizona), Amanda J. Shelley(University of Toronto), Alexander N. Ortega(University of Hawaiʻi at Mānoa), Yuliya Lytvyn(University Health Network)
Journal of the American Academy of Dermatology
June 1, 2025
10.1016/j.jaad.2025.06.045
Cited by 5

Related Papers

Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470
Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity
|British Journal of Dermatology|2017|467
Diabetic foot ulcers
|Journal of the American Academy of Dermatology|2013|363
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
|The Lancet|2023|318
Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment
|American Journal of Clinical Dermatology|2017|314